These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7816246)

  • 21. [Adequate Ca level for dialysis patient (study on medical therapy for secondary hyperparathyroidism in dialysis patient)].
    Sawada K; Sawada S; Nakagawa M; Ioka J; Tatsumi T; Yoneda Y; Maki K
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):813-9. PubMed ID: 1479721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?
    Fournier A; Moriniere P; Boudaillez B; Renaud H; Marie A; Westeel PF; Hocine C; Belbrik S
    Nephrol Dial Transplant; 1987; 2(6):498-503. PubMed ID: 3126450
    [No Abstract]   [Full Text] [Related]  

  • 23. [Letter: Is it necessary to wait for the time of parathyroidectomy to treat the hyperparathyroidism of patients with chronic renal insufficiency].
    Bernheim J; Faivre JM
    Nouv Presse Med; 1975 Feb; 4(8):591. PubMed ID: 1129122
    [No Abstract]   [Full Text] [Related]  

  • 24. [Skeletal complications of renal insufficiency].
    Fujimori A; Fukagawa M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():706-10. PubMed ID: 15035213
    [No Abstract]   [Full Text] [Related]  

  • 25. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 26. Natural course of secondary hyperparathyroidism after successful renal transplantation.
    Roof BS; Piel CF; Carpenter BJ; Gordan GS; Kountz S; Belzer F
    Proc Clin Dial Transplant Forum; 1971; 1():11-20. PubMed ID: 4951041
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal osteodystrophy: a pediatric perspective, 2005.
    Langman CB
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():42-7. PubMed ID: 16039889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic impact of vitamin D treatment on chronic kidney disease patients.
    Ramos R; Alcázar R; Otero A; de Francisco AL; del Pino MD
    Nefrologia; 2011; 31(5):528-36. PubMed ID: 21959719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges.
    Komaba H; Shiizaki K; Fukagawa M
    Expert Opin Biol Ther; 2010 Dec; 10(12):1729-42. PubMed ID: 21058933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D deficiency in CKD: why should we care?
    Holick MF
    Am J Kidney Dis; 2005 Jun; 45(6):1119-21. PubMed ID: 15957143
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renal osteopathy].
    Zazgornik J
    Wien Med Wochenschr; 1990 Oct; 140(18-19):490-2. PubMed ID: 2251845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Review on internal medicine, 1973--nephrology. 6. Calcium metabolism in patients on regular dialysis treatment (author's transl)].
    Ogura Y
    Nihon Naika Gakkai Zasshi; 1974 Apr; 63(4):353-63. PubMed ID: 4605927
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperparathyroidism and bone disease after renal transplantation.
    Pavlović D; Orlić L
    Acta Med Croatica; 2002; 56(2):41-3. PubMed ID: 12596622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic renal insufficiency and calcium].
    Ogura Y; Sakai S; Kawaguchi Y; Yamamoto M; Kimura Y
    Nihon Rinsho; 1974 Mar; 32(3):463-70. PubMed ID: 4603390
    [No Abstract]   [Full Text] [Related]  

  • 36. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [News in the management of calcium and phosphorus metabolism disorders for patient treated by hemodialysis].
    Van Overmeire L; Delanaye P; Krzesinski JM
    Rev Med Suisse; 2005 Aug; 1(30):1960-5. PubMed ID: 16200940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).
    Goldsmith DJ; Massy ZA; Brandenburg V
    Semin Nephrol; 2014 Nov; 34(6):660-8. PubMed ID: 25498384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vitamin D metabolism and chronic kidney insufficiency].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on renal osteodystrophy: pathogenesis and clinical management.
    Sakhaee K; Gonzalez GB
    Am J Med Sci; 1999 Apr; 317(4):251-60. PubMed ID: 10210362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.